Stock Detail
Videos
Fertility Frontiers: Leading Edge Technologies Addressing the Fertility Market KOL Panel
This panel explores the dynamic realm of leading-edge technologies within the fertility market. Speakers include Steve Shum, CEO at INVO Bioscience and David Wolf, CEO at Hamilton Thorne Ltd. This KOL Panel was recorded during the Lytham Partners Fall 2023 Investor...
INVO Bioscience (INVO) Company Webcast
INVO Bioscience is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility care accessible and inclusive to people around the world. Our commercialization strategy is focused on the...
INVO Bioscience (INVO) Fireside Chat
During this fireside chat we welcome INVO Bioscience, ticker symbol of INVO on the NASDAQ and their CEO, Mr. Steve Shum. INVO is a healthcare services fertility company dedicated to expanding the assisted reproductive technology ("ART") marketplace by making fertility...
News
INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
SARASOTA, Fla., Aug. 14, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment and acquisition of fertility clinics, and with the...
INVO Reports Record First Quarter 2024 Financial Results
353% Revenue Growth with improvement in Adjusted EBITDASARASOTA, Fla., May 15, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the...
INVO Reports Fourth Quarter and Full Year 2023 Financial Results
SARASOTA, Fla., April 16, 2024 -- INVO Bioscience, Inc. (Nasdaq: INVO) ("INVO" or the "Company"), a healthcare services fertility company focused on expanding access to advanced treatment worldwide through the establishment and acquisition of fertility clinics, and...